(Q40718615)

23 September 2017

title

The incurable wound revisited: progress in human rabies prevention? (English)

1 reference

23 September 2017

0 references

Charles Edward Rupprecht

series ordinal

4

object named as

Rupprecht CE

1 reference

23 September 2017

Hanlon CA

1

1 reference

23 September 2017

Niezgoda M

series ordinal

2

1 reference

23 September 2017

Morrill PA

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

17-19

1 reference

23 September 2017

page(s)

2273-2279

1 reference

A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

A review of the economics of the prevention and control of rabies. Part 2: Rabies in dogs, livestock and wildlife

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Rabies--risk of exposure and current trends in prevention of human cases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Current recommendations for the prophylaxis and treatment of rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Failure of rabies postexposure treatment in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Failure of postexposure treatment of rabies in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Additional reports of failure to respond to treatment after rabies exposure in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Incidence of reactions to antirabies horse serum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

A Rabies-Specific Human Monoclonal Antibody That Protects Mice Against Lethal Rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Development of human monoclonal antibodies to rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Use of hyperimmune anti-rabies serum concentrates in experimental rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Animal models in the pathogenesis and treatment of rabies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

Development of Orphan Vaccines: An Industry Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900516-8

7 January 2021

10.1016/S0264-410X(00)00516-8

Identifiers

DOI

1 reference

23 September 2017

1 reference